Concepedia

Lydia Kamaruzaman

LK

Statistics

Publications

7

Citations

334

H-Index

7

Active since

2018

Affiliations

University Kebangsaan Malaysia Medical Centre(Current)

University of Oxford

Lydia Kamaruzaman is an author at University Kebangsaan Malaysia Medical Centre specializing in medicine, chronic kidney disease, and renal disease.

Publications per year

2018–2024

7

Publications

7

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Catheter-Related Bloodstream Infections and Catheter Colonization among Haemodialysis Patients: Prevalence, Risk Factors, and Outcomes

Shamira Shahar, Ruslinda Mustafar, Lydia Kamaruzaman et al. · International Journal of Nephrology · 2021 · 47 citations · Full text

Medicine, Infectious Diseases, Nephrology +13

Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: a 6-months open-label, randomized controlled trial

Mohd Noor Azreey Mukri, Wei Yen Kong, Ruslinda Mustafar et al. · PubMed · 2018 · 46 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Work disability and employment status among advanced chronic kidney disease patients

Shing Shen Bay, Lydia Kamaruzaman, Rozita Mohd et al. · PLoS ONE · 2024 · 19 citations · Full text

Medicine, Nephrology, Dialysis +14

1–5 of 7